Section Arrow
SRDX.NASDAQ
- Surmodics
Quotes are at least 15-min delayed:2024/06/09 11:10 EDT
Last
 41.95
-0.01 (-0.02%)
Day High 
42 
Prev. Close
41.96 
1-M High
42.36 
Volume 
191.21K 
Bid
41.88
Ask
67.16
Day Low
41.9 
Open
41.96 
1-M Low
30.98 
Market Cap 
598.41M 
Currency USD 
P/E 43.71 
%Yield
10-SMA 39.79 
20-SMA 36.77 
50-SMA 31.56 
52-W High 42.36 
52-W Low 19.62 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.96/0.19
Enterprise Value
630.79M
Balance Sheet
Book Value Per Share
8.69
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
132.58M
Operating Revenue Per Share
9.16
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
VEROVenus Concept0.93+0.3433+58.51%-- 
ASXCAsensus Surgical0.332+0.0972+41.40%-- 
AEMDAethlon Medical0.5859+0.0358+6.51%-- 
ABTAbbott Laboratories107.58+3.31+3.17%32.48PE
MDTMedtronic plc84.07+1.73+2.10%26.14PE
Quotes are at least 15-min delayed:2024/06/09 11:10 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions todifficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.